For the quarter ending 2025-09-30, AIM made $26K in revenue. -$3,284K in net income. Net profit margin of -12630.77%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 26 | 25 | 43 | 35 |
| Production costs | 68 | 10 | 8 | 8 |
| Research and development | 607 | 1,174 | 1,808 | 1,437 |
| General and administrative | 1,798 | 1,487 | 4,022 | 3,079 |
| Total costs and expenses | 2,473 | 2,671 | 5,837 | 4,524 |
| Operating loss | -2,447 | -2,646 | -5,794 | -4,489 |
| Interest and other income | - | 10 | 546 | 718 |
| Gain (loss) on investments | -1 | -9 | -140 | 273 |
| Interest and other income | 3,052 | - | - | - |
| Interest expense and other finance costs | 148 | 149 | 102 | 202 |
| Issuance cost | 433 | - | - | - |
| (loss) on warrant issuance | - | - | 0 | - |
| Loss on issuance of warrants | -3,977 | 0 | - | - |
| (loss) gain from sale of income tax operating losses | - | - | 401 | - |
| Change in fair value of warrants | -670 | - | - | - |
| Net loss | -3,284 | -2,794 | -5,892 | -3,700 |
| Basic loss per share | 1.57 | -3.68 | -0.11 | -0.06 |
| Diluted loss per share | 1.57 | -3.68 | -0.11 | -0.06 |
| Weighted average shares outstanding basic | 2,093,446 | 759,289 | -27,248,811.5 | 57,677,016 |
| Weighted average shares outstanding diluted | 2,093,446 | 759,289 | -27,248,811.5 | 57,677,016 |
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM)